Valuation: SMS Pharmaceuticals Limited

Market Cap 4.15TCr 44Cr 39Cr 36Cr 33Cr 61Cr 62Cr 433.75Cr 172.22Cr 2.17TCr 163.66Cr 160.15Cr 6.89TCr P/E 2025
27.3x
P/E 2026 33.6x
Enterprise Value 4.47TCr 47Cr 42Cr 39Cr 35Cr 66Cr 67Cr 467.13Cr 185.47Cr 2.34TCr 176.25Cr 172.47Cr 7.42TCr EV / Sales 2025
2.75x
EV / Sales 2026 4.31x
Free-Float
24.01%
Yield 2025
0.19%
Yield 2026 0.11%
1 day+5.97%
1 week+1.88%
Current month-7.09%
1 month-6.78%
3 months+16.19%
6 months+11.62%
Current year+42.65%
1 week 405
Extreme 405
446
1 month 405
Extreme 405
489
Current year 293.15
Extreme 293.15
494.45
1 year 270.1
Extreme 270.1
494.45
3 years 113.3
Extreme 113.3
494.45
5 years 54.55
Extreme 54.55
494.45
10 years 24
Extreme 24
494.45
Manager TitleAgeSince
Chief Executive Officer 66 30/08/1990
Director of Finance/CFO - 13/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 30/08/1990
Director/Board Member 38 05/06/2020
Director/Board Member 48 29/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+5.97%+1.88%+48.75%+280.09% 41Cr
+0.22%+3.35%+55.30%+125.65% 1,14000Cr
+0.91%+5.89%+41.14%+80.36% 64TCr
-0.12%+1.31%+25.62%+97.24% 51TCr
+0.63%+4.97%+47.12%+68.18% 38TCr
+0.86%-1.26%+62.10%+34.36% 35TCr
+1.02%+3.69%+23.73%+51.35% 29TCr
-0.25%+3.40%+2.31%+23.38% 27TCr
+0.75%+5.41%+53.53%+66.09% 24TCr
+0.25%+3.93%+31.54%+102.65% 20TCr
Average +0.73%+2.24%+39.11%+92.93% 40.14TCr
Weighted average by Cap. +0.02%+2.98%+42.01%+84.58%

Financials

2025 2026
Net sales 782.75Cr 8.23Cr 7.39Cr 6.82Cr 6.19Cr 12Cr 12Cr 82Cr 33Cr 410.07Cr 31Cr 30Cr 1.3TCr 888.64Cr 9.34Cr 8.39Cr 7.75Cr 7.02Cr 13Cr 13Cr 93Cr 37Cr 465.55Cr 35Cr 34Cr 1.48TCr
Net income 69Cr 72.7L 65.29L 60.26L 54.64L 1.02Cr 1.03Cr 7.23Cr 2.87Cr 36Cr 2.73Cr 2.67Cr 114.84Cr 101.99Cr 1.07Cr 96.32L 88.89L 80.6L 1.51Cr 1.53Cr 11Cr 4.24Cr 53Cr 4.03Cr 3.94Cr 169.41Cr
Net Debt 269.27Cr 2.83Cr 2.54Cr 2.35Cr 2.13Cr 3.98Cr 4.03Cr 28Cr 11Cr 141.07Cr 11Cr 10Cr 447.27Cr 319.08Cr 3.36Cr 3.01Cr 2.78Cr 2.52Cr 4.71Cr 4.77Cr 33Cr 13Cr 167.16Cr 13Cr 12Cr 530.01Cr
Projected Income Statement - Annual - SMS Pharmaceuticals Limited
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,617
Date Price Change Volume
27/26/27 ₹442.80 +5.97% 3,36,336
26/26/26 ₹417.85 +0.78% 2,25,037
23/26/23 ₹414.60 -3.28% 4,58,393
22/26/22 ₹428.65 -1.29% 3,56,308
21/26/21 ₹434.25 -0.09% 3,03,731

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - SMS Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock